Kobayashi Takaomi, Takeda Kohei, Ohashi Atsushi, Makoto Makoto, Sugiyama Satoshi
Department of Materials Science and Technology, Nagaoka University of Technology, Nagaoka, Japan.
Ther Apher Dial. 2009 Feb;13(1):19-26. doi: 10.1111/j.1744-9987.2009.00651.x.
Bisphenol A (BPA)-imprinted membranes were prepared by hybridization of a porous polysulfone (PSu) scaffold with a BPA-imprinted polymer powder copolymerized with dimethacrylate BPA and divinylbenzene. When exposed to a donor calf serum (DCS) solution containing 0.05-100 microM of BPA, the imprinted hybrid membrane (10 x 10 mm(2)) bound BPA at a capacity of 6.0 x 10(-9)-20 x 10(-6) mol/g-membrane. In contrast, a similar sized powder-free PSu membrane bound BPA at a capacity of only 1.5 x 10(-9)-1.9 x 10(-6) mol/g-membrane. The difference in the binding capacities of the two membranes was attributed to the BPA-imprinted powder hybridized in the PSu membrane. Clinical analyses confirmed that the DCS parameters remained nearly constant before and after the BPA binding. This observation suggests that BPA was removed selectively from the DCS solution by the imprinted hybrid membrane. Together, these results demonstrate that the molecular imprinting technique is very useful as a novel medical material adsorbent that can reduce exposure to the endocrine disruptor, BPA.
通过将多孔聚砜(PSu)支架与与双甲基丙烯酸双酚A(BPA)和二乙烯基苯共聚的BPA印迹聚合物粉末杂交,制备了BPA印迹膜。当暴露于含有0.05 - 100微摩尔BPA的供体小牛血清(DCS)溶液中时,印迹杂交膜(10×10毫米²)以6.0×10⁻⁹ - 20×10⁻⁶摩尔/克膜的容量结合BPA。相比之下,类似尺寸的无粉末PSu膜结合BPA的容量仅为1.5×10⁻⁹ - 1.9×10⁻⁶摩尔/克膜。两种膜结合能力的差异归因于PSu膜中杂交的BPA印迹粉末。临床分析证实,BPA结合前后DCS参数几乎保持不变。这一观察结果表明,印迹杂交膜可从DCS溶液中选择性去除BPA。总之,这些结果表明分子印迹技术作为一种新型医用材料吸附剂非常有用,可减少对内分泌干扰物BPA的暴露。